CELLENKOS
Cellenkos is a clinical-stage biotech company focused on the development and commercialization of transformative novel allogeneic Treg cell therapies to treat autoimmune and inflammatory disorders.
CELLENKOS
Social Links:
Industry:
Biotechnology
Founded:
2016-01-01
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.cellenkosinc.com
Status:
Active
Contact:
(800) 217-8247
Total Funding:
15 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics Google Universal Analytics Mobile Non Scaleable Content Euro IPv6 Google Apps For Business
Current Employees Featured
Founder
Investors List
BVCF
BVCF investment in Series A - Cellenkos
Official Site Inspections
http://www.cellenkosinc.com Semrush global rank: 5.77 M Semrush visits lastest month: 1.45 K
- Host name: 104.21.94.178
- IP address: 104.21.94.178
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Cellenkos"
Cellenkos, Inc
Dr. Mukherjee is an Associate Professor of Medicine at Columbia University and a Staff Physician at Columbia University Medical Center. Dr. Mukherjee is the author of The Emperor of All …See details»
Cellenkos, Inc
Defective T-REGS lead to autoimmune diseases Defective T-REGs can no longer protect the body from the harmful effect of T cells which lead to certain autoimmune diseases including …See details»
Cellenkos - Crunchbase Company Profile & Funding
Cellenkos is a clinical-stage biotech company focused on the development and commercialization of transformative novel allogeneic Treg cell therapies to …See details»
Cellenkos, Inc
Headquartered in Houston, Texas, and founded in September of 2016, Cellenkos Inc. is building a fantastic team comprised of individuals that are courageous, energetic, passionate, inclusive, …See details»
Cellenkos, Inc. - LinkedIn
Cellenkos, Inc. | 1,003 followers on LinkedIn. Developing off-the-shelf T regulatory (Treg) cell therapies for rare inflammatory diseases and autoimmune disorders. | Cellenkos is a clinical …See details»
Cellenkos Company Profile | Management and Employees List
Www.cellenkosinc.com . Cellenkos Profile and History. Cellenkos is a clinical-stage biotech company focused on the development and commercialization of transformative novel …See details»
Cellenkos, Inc. Overview | SignalHire Company Profile
Organization Website: cellenkosinc.com : Phone Number: 832-962-7628: Cellenkos, Inc. industries BiotechSee details»
Cellenkos - Overview, News & Similar companies | ZoomInfo.com
Dec 31, 2020 Cellenkos contact info: Phone number: (800) 217-8247 Website: www.cellenkosinc.com What does Cellenkos do? Cellenkos is a clinical-stage biotech …See details»
Cellenkos CEO and Key Executive Team | Craft.co
Cellenkos's Chief Operating Officer is Tara Sadeghi. Cellenkos's key executives include Tara Sadeghi and 1 others.See details»
Cellenkos, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Cellenkos, Inc. with its drug pipeline, therapeutic area, technology platform, 5 clinical trials, 23 news, and 6 literature, Disease Domain:Immune System Diseases, Nervous System …See details»
Cellenkos Inc Company Profile | Houston, TX - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Cellenkos Inc of Houston, TX. Get the latest business insights from Dun & Bradstreet.See details»
Cellenkos 2025 Company Profile: Valuation, Funding & Investors
Publication ID Patent Title Status First Filing Date Technology (CPC) Citations; US-20230066340-A1: Populations of enriched regulatory t cells and methods for producing sameSee details»
Cellenkos, Inc
CRANE® Platform C ord Blood T-R egulatory Cells; A ctivated And E nriched.. Cellenkos’ proprietary CRANE® technology allows for cell enrichment and differentiation such that each …See details»
Cellenkos - VentureRadar
"Cellenkos is an early stage clinical biotechnology company that focuses on umbilical cord blood derived T-regulatory cellular therapies for treating autoimmune diseases and inflammatory …See details»
Cellenkos Company Profile - Office Locations, Competitors, …
Cellenkos has 1 employees at their 1 location. See insights on Cellenkos including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Cellenkos Company Profile: Overview and Full News Analysis
Cellenkosinc.com. Overview: Cellenkos. Cellenkos is a Clinical-Stage Biotechnology Company based in Texas that specializes in developing Allogeneic, Tissue-Targeted, Immune T …See details»
Cellenkos Inc Overview - Salary.com
Discover essential details about Cellenkos Inc, including address, contact, and journey of our company's evolution.See details»
Cellenkos, Inc
Cellenkos Announces First Patient Dosed with CK0803 Cell Therapy for Treatment of Amyotrophic Lateral Sclerosis may 2nd 2023 HOUSTON, May 2, 2023 /PRNewswire/ -- …See details»
Cellenkos - Products, Competitors, Financials, Employees, …
Cellenkos is an early-stage clinical biotechnology company that focuses on umbilical cord blood-derived T-regulatory cellular therapies for treating autoimmune diseases and inflammatory …See details»
Cellenkos, Inc
CXCR4 Enriched Umbilical Cord Blood Derived Treg Cells Preferentially Home To Resolve Bone Marrow Inflammation. Cytotherapy Vol. 25 Issue 6 Supplement S246-S247.See details»